- Benchmark ASINB0F9XZZXRX
- MarketplaceUS
- Category ID11063531
- Analyzed Products
- Keywordskin care
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥4.19estimated
- Data Date2026-07-30
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，结论很直接：已经是低利润、低增量、近乎没有新品牌机会的市场。 当前可验证数据里，新品牌数量是0，新上架产品也是0；能拿到的唯一清晰样本是老品牌 starfa lab 的 B0F9XZZXRX，月销约4000件、月收入约279.6万元，但利润率只有6.53%，已经落在价格战区间，说明这里不是“能不能卖”，而是“卖得越多越薄”。
证据也很一致：没有健康的新进入样本，只有一个老品牌在硬扛。 从产品失败原因看，B0F9XZZXRX 直接卡在“低利润、缺乏差异化、市场太小或竞争太激烈”三点上；它定价6.99美元，评分4.6、评论410，评论量已经超过你定义的常规健康小卖家区间，更像是激进营销/强势守盘的竞争者，不是小商家可复制的成功案例。市场节奏上也没有看到利润改善的趋势，按月和按年口径都没有出现新释放带来利润上升的迹象，说明竞争不是在缓和，而是早就被压成了薄利场。
预算不是问题，机会才是问题。 你的500000元预算足够覆盖单个ASIN前期投入，但这只够前几个月的供货、物流和投放，不包含研发、品牌和认证；放到这个市场里，即使大品牌进来也只是拿更多钱去卷更薄的毛利，小商家更没有真正的健康样本可抄。可跟随的只有反面样本：starfa lab / B0F9XZZXRX，应该避免复制这种低客单、低毛利、靠规模硬推的打法。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
Old Brands
#Budget Requirement
Listing结论先说：这个市场不适合进入，且用户预算完全足够，但不该拿去打这场仗。 现在看到的是明显的低利润、强竞争信号：已识别产品里盈利率是0%，新上架产品盈利率也是0%，这已经不是“能不能做”的问题，而是典型的价格战/高压竞争环境。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
Alternatives- 一次性点胶/勾线替代方案：用廉价一次性木棒、硅胶指缘棒或塑料拨棒完成取胶、点涂和简单拉线，几乎不用清洗，适合只偶尔做美甲的人。
- 成套基础美甲笔刷替代方案：直接买更便宜的多支入门笔刷套装（平刷+细线笔+点花笔），覆盖面更广，单支损坏也不心疼。
- 自带细嘴/刷头的凝胶产品替代方案：改用带刷头的甲油胶、建构胶或延长胶，减少对专用双头笔刷的依赖，操作门槛更低。
- 甲片贴/免打磨贴替代方案：如果目的是快速做出“像做了美甲”的效果，可用甲片或免胶甲贴，省去建构和塑形步骤。
- 预制延长甲模板/甲片替代方案：用现成的延长甲片、法式贴片或预成型甲片来代替手工刷建构胶，速度更快，对工具要求更低。
- 美甲海绵/硅胶印章替代方案：若主要做渐变、晕染或简单图案，可用海绵、硅胶印章等低价工具替代精细画笔。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入：样本里可判断盈利性的产品里，盈利率是0%，新上架产品盈利率也是0%，而且核心样本 B0F9XZZXRX 虽然月销约4000件、月收入约27960美元，但利润率只有6.53%，已经落在价格战区间。再加上近期发布趋势没有显示出清晰的增长机会，结论很直接：这是一个高竞争、低利润、偏饱和的市场，大小卖家都不应贸然进入。
证据很清楚。唯一拿到的建立品牌样本是 starfa lab，属于老品牌，它的单品 B0F9XZZXRX 定价6.99美元，评分4.6、评论410，但仍然不赚钱，说明这个价位和结构下连有销量的老品牌都被压到很薄。该产品的失败原因是低利润、同质化强、市场太小或竞争太激烈，而且评论数超过200-300，按你的规则更像是强营销/激进打法的竞争者，不是小卖家可复制的健康案例。用户预算500000元看起来够覆盖单个ASIN前期投入，但这里的问题不是“钱够不够”，而是投入后大概率还是会被压进低毛利陷阱。可参考的只有反面样本：starfa lab / B0F9XZZXRX，应该避免模仿这种低客单、低毛利、靠规模硬推的打法。
短结论：不要进入。 大品牌如果硬进，也只是拿更多预算去卷低毛利；小卖家更没有健康的成功样本可抄，所谓“成功”也不像真正的小卖家成功。
Old brand with the most profitable new productsstarfa lab
Recent Monthly Revenue (USD):$27,960.00(4000pcs/month)B0F9XZZXRX (4.6/5 (410 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0F9XZZXRX (4.6/5 (410 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%Sales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入。 当前样本里只有 1 个可判断产品，且它的利润率只有 6.53%，已经落在明显的价格战区间；同时核心品牌 starfa lab 作为老品牌，产品 B0F9XZZXRX 月销 4000、月营收 27,960 美元，但仍然不赚钱，说明这里更像是靠低价和高销量硬撑，而不是靠健康利润活着。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0F9XZZXRXstarfa lab2025-05-27No$6.994000pcs$27960.06.53%$1825.79No profitable product data available for new products#New Product Success Rates
Listing这个市场不适合进入，结论很明确：已经是价格战区，且对新品牌和小商家都不友好。 现有样本里几乎没有可验证的利润，能看到的唯一可量化样本 starfa lab 的 B0F9XZZXRX 虽然月销约 4000 件、月营收约 279.6 万，但利润率只有 6.53%，低于你要求的 10% 警戒线，说明销量看起来强，实际上是在薄利硬扛。
No data availableNo data availableNo data available#Success Rate by Entry Time
Listing这个市场不值得进入，结论是直接放弃。 数据里几乎没有可复制的新品牌成功样本：新品牌数量为0，新上架产品为0，整体可判定为没有真实的新进入机会；同时现有可见样本里，starfa lab 的 ASIN B0F9XZZXRX 只有 6.53% 利润率，远低于你要求的 15% 可接受线，且 410 条评价、月销 4000，明显更像老品牌的强势守盘，而不是小商家能轻松复制的路径。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases